NASDAQ: NEUPNeuphoria Therapeutics Inc Stock Ownership - Who owns Neuphoria Therapeutics?
Insider buying vs selling
Have Neuphoria Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when NEUP insiders and whales buy or sell their stock.
NEUP Shareholders
What type of owners hold Neuphoria Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Spyros Papapetropoulos | 341.48% | 5,999,940 | $29.60M | Insider |
| Peter Miles Winston Davies | 15.37% | 269,984 | $1.33M | Insider |
| David Ian Wilson | 14.34% | 251,939 | $1.24M | Insider |
| Alan Fisher | 5.69% | 100,000 | $493.30k | Insider |
| Lynx1 Capital Management LP | 2.61% | 45,806 | $225.96k | Institution |
| Jane Street Group LLC | 0.76% | 13,311 | $65.66k | Institution |
| Merck Co Inc | 0.57% | 10,027 | $49.46k | Institution |
| Bank Of America Corp | 0.37% | 6,484 | $31.99k | Institution |
| Ubs Group Ag | 0.17% | 2,978 | $14.69k | Institution |
| Rhumbline Advisers | 0.06% | 1,106 | $5.46k | Institution |
NEUP vs Biotech Stocks
Neuphoria Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.